GlassScriptPhysician profile
Annie Stadstad
NPI 1386041309
$1,963.64
in general payments reported to CMS, 2019-2025
20 companies · $77.83 in 2025
The $77.83 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $707 · 2022: $479 · 2023: $661 · 2024: $38.14 · 2025: $77.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.10 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $309.63 | 2021-2024 | |
| E.R. Squibb & Sons, L.L.C. | $280.56 | 2021-2023 | Camzyos, Eliquis |
| Amgen INC. | $224.35 | 2021-2023 | Repatha |
| Pfizer INC. | $213.79 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $187.30 | 2022-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $145.80 | 2021-2023 | Jardiance |
| Esperion Therapeutics, INC. | $110.02 | 2021 | |
| Novo Nordisk INC | $109.65 | 2022 | |
| Merck Sharp & Dohme LLC | $74.29 | 2022-2023 | Verquvo |
| Atricure, INC. | $46.89 | 2023 | |
| Stryker Corporation | $40.58 | 2025 | Flowtriever |
| Integra Lifesciences Corporation | $37.25 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.68 | 2021-2023 | Lifevest |
| Edwards Lifesciences Corporation | $29.82 | 2023 | |
| Abbott Laboratories | $24.98 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $24.83 | 2024 | Prevena |
| Kiniksa Pharmaceuticals, LTD. | $18.39 | 2023 | Arcalyst |
| Abiomed | $18.19 | 2023 | Impella |
| Amarin Pharma, INC. | $16.44 | 2022 | |
| Boston Scientific Corporation | $14.20 | 2023 | Vigilant X4 Crt-D |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annie Stadstad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.